Target intelligence / Profile preview

Pulmonary stretch receptor and vagal sensory nerve fiber (PSR)

Target
PSR
Molecular classification
Ion channel, Receptor, Other
01

Overview

Pulmonary stretch receptors (PSRs) are specialized mechanoreceptors located within the airway smooth muscle and lung parenchyma that sense lung inflation and transmit signals to the brain via vagal sensory nerve fibers [1.1.5, 1.4.2]. These receptors are primarily responsible for the Hering-Breuer reflex, which prevents over-inflation of the lungs by inhibiting inspiration and prolonging expiration [1.1.1, 1.1.5]. The molecular basis of mechanotransduction in PSRs is largely attributed to the Piezo2 ion channel, which is essential for sensing lung volume and maintaining normal breathing patterns [1.2.1, 1.2.2]. Vagal sensory fibers also include rapidly adapting receptors (RARs) and C-fibers, which express various receptors such as P2X3, TRPV1, and TRPA1 that respond to chemical irritants and inflammatory mediators [1.1.2, 1.3.1]. In clinical practice, this system is targeted by antitussive agents like benzonatate, which acts as a local anesthetic on the stretch receptors to suppress the cough reflex [1.3.2, 1.4.1]. Additionally, novel therapies like gefapixant target P2X3 receptors on vagal afferents to treat chronic refractory cough [1.3.1, 1.3.2]. Dysregulation of these sensory pathways is implicated in the pathophysiology of asthma, COPD, and idiopathic pulmonary fibrosis, where hypersensitivity of the fibers leads to excessive coughing and dyspnea [1.1.2, 1.3.2]. Understanding the interaction between these receptors and the autonomic nervous system is crucial for developing targeted treatments for respiratory distress and chronic airway diseases [1.1.2, 1.3.2].

Other names
Slowly adapting pulmonary stretch receptorSARRapidly adapting pulmonary stretch receptorRARHering-Breuer receptorVagal afferent fiberBronchopulmonary stretch receptorLung mechanoreceptor
02

Mechanism of action

Inhibition of mechanosensitive ion channels (e.g., Piezo2), blockade of voltage-gated sodium channels on sensory neurons, and antagonism of purinergic P2X3 receptors on vagal afferents.

03

Biological functions

Signal transductionOther
04

Disease associations

InflammationOther
05

Safety considerations

Respiratory depressionLoss of protective cough reflexAspiration riskVocal cord dysfunctionOropharyngeal numbness
06

Interacting drugs

Benzonatate

5 more in the full profile.

07

Biomarkers

Cough frequencyTidal volumeRespiratory rateForced expiratory volume in 1 second (FEV1)

Beyond the preview

Go deeper on Pulmonary stretch receptor and vagal sensory nerve fiber (PSR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pulmonary stretch receptor and vagal sensory nerve fiber (PSR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call